Evidence map›Paper›PMID 37438812›Full record

ArticleHarm reduction journal2023

The motives and methods of methamphetamine and 'heroin' co-use in West Virginia.

Jeff Ondocsin, Nicole Holm, Sarah G Mars, Daniel Ciccarone

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ketamine enhancement of dexmedetomidine attenuation of methamphetamine-induced agitation in rats.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
  5. Article
  6. The Donovan Memorial Lecture: 'Fentanyl-Plus': A New Era of Fentanyl Polydrug Combinations in the North American Overdose Crisis.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeff Ondocsin *Department of Family and Community Medicine, University of California, 500 Parnassus Avenue, MU3E, San Francisco, CA, 94143, USA. jeffrey.ondocsin@ucsf.edu.
Nicole Holm *Department of Family and Community Medicine, University of California, 500 Parnassus Avenue, MU3E, San Francisco, CA, 94143, USA.
Sarah G MarsDepartment of Family and Community Medicine, University of California, 500 Parnassus Avenue, MU3E, San Francisco, CA, 94143, USA.
Daniel CiccaroneDepartment of Family and Community Medicine, University of California, 500 Parnassus Avenue, MU3E, San Francisco, CA, 94143, USA.
University of California, San Francisco · US

Funding

Synthetics in Combination (SYNC)R01DA054190 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DANIEL H CICCARONE · 2021 to 2026
$4.3M
Heroin in TransitionR01DA037820 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CICCARONE, DANIEL H · 2015 to 2019
$3.7M
NIDA NIH HHS R01 DA037820NIDA NIH HHS R01 DA054190
6 · The paper itself

Abstract

backgroundOpioid and methamphetamine co-use is increasing across the USA with overdoses involving these drugs also rising. West Virginia (WV) has led the US in opioid overdose death rates since at least 2013 and rising co-use of methamphetamine with opioids has played a greater role in deaths over the last 5 years.

methodsThis study used rapid ethnography to examine methods and motivations behind opioids and methamphetamine co-use from the viewpoint of their consumers. Participants (n = 30) were people who injected heroin/fentanyl also using methamphetamine who participated in semi-structured interviews.

resultsWe found multiple methods of co-using opioids and methamphetamine, whether alternately or simultaneously and in varying order. Most prioritized opioids, with motives for using methamphetamine forming three thematic categories: 'intrinsic use', encompassing both inherent pleasure of combined use greater than using both drugs separately or for self-medication of particular conditions; 'opioid assisting use' in which methamphetamine helped people manage their existing heroin/fentanyl use; and 'reluctant or indifferent use' for social participation, reflecting methamphetamine's low cost and easy availability.

conclusionsMethamphetamine serves multiple functions among people using opioids in WV. Beliefs persist that methamphetamine can play a role in preventing and reversing opioid overdose, including some arguments for sequential use being protective of overdose. 'Reluctant' uptake attests to methamphetamine's social use and the influence of supply. The impact on overdose risk of the many varied co-use patterns needs further investigation.

Indexed as

FentanylHealth Knowledge, Attitudes, PracticeHeroinMethamphetamineMotivationAdultFemaleHeroin DependenceHumansInterviews as TopicMalePleasureSelf MedicationSocial InteractionWest VirginiaFentanylHeroinMethamphetamineEthnographyInjectionMethamphetamineOpioidPolysubstance useSubstance-related disorders

Identifiers

PMID37438812
PMCPMC10339587
OpenAlexW4384071089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.